Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


In this issue

Research Article

Dipstick showing urinary tract infection urinary tract infection (UTI)

NHS Grampian project: treating uncomplicated lower urinary tract infection in community pharmacySubscription


Urinary tract infections (UTIs) are one of the most common conditions seen in female patients in general practice (GP) and account for 1–3% of all GP consultations each year in the UK. Over-the-counter (OTC) treatments for UTIs currently available in community pharmacy only attempt to relieve symptoms, and do not address the bacterial infection. The Grampian project was developed to provide treatment of uncomplicated UTIs through community pharmacies by means of a Patient Group Direction ...


British Army servicemen in desert fatigues marching

The importance of the British Army’s slick drug-testing operationsSubscription


When the UK was engaged in military operation in Iraq and Afghanistan in 2007, the UK press reported a fivefold increase in the cocaine-positive rate of British soldiers, which was followed by a switch from cocaine to mephedrone. What can we learn from this, in the light of a current reported high rate of positive compulsory drug test results in the British Army?

Blood pressure concept

Rethinking the clinical interpretation of blood pressure readings taken in pharmaciesSubscription


New research into blood pressure measurements taken in different settings could help pharmacists interpret blood pressure readings better and help them offer appropriate advice to patients.

CPD article

3D scan showing brain haemorrhage stroke

Stroke: classification and diagnosisSubscription


In light of the many pressures currently facing the NHS, as well as an ever increasing ageing population, pharmacists and healthcare professionals should be aware of the risk factors for stroke, its classification and diagnosis.

Short communications

Preliminary results of a specialist pharmacist-led polypharmacy clinic for patients with prostate cancerSubscription

Polypharmacy — the use of multiple medications by a patient — generally occurs in older adults aged 65 years and over. The increasing number of treatment options and an ageing population mean that, anecdotally, we are seeing more patients with co-morbidities. The multiple specialisms involved in various aspects of cancer patient care can lead to no one taking responsibility for the patient as a whole, which may result in poorer therapeutic outcomes and inappropriate polypharmacy

Patients need access to comprehensible information and their summary care recordsSubscription

This letter is in response to ‘Health literacy, medication adherence and thriving healthcare systems: connecting the dots’.

Primary-care overprescribing of rivaroxaban in patients without atrial fibrillationSubscription


There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only ...

Impact of measures introduced to control meropenem consumption in a district general hospital over a 2-year periodSubscription

Meropenem is a broad-spectrum antipseudomonal carbapenem antibiotic. Controlling the prescribing of carbapenems is important in our efforts to curb the development of carbapenem-resistant Gram-negative organisms, which already pose a serious health threat to many parts of the UK.

Revisiting NICE's approval of 'breakthrough' drugs palbociclib and ribociclibSubscription


Claims of cancer drugs’ survival benefits must be accurate. To avoid fashion and fads, we must carefully examine the clinical and economic implications of newly approved cancer drugs before we seat them on the ‘breakthrough’ throne.

Clinical Pharmacist

cover cp 10 1 18

CP January 2018, Vol 10, No 1

Cover Story:

NHS Grampian project: treating uncomplicated lower urinary tract infection in community pharmacy

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.